Tumor biomarkers, such as CEA, CA125, NSE, CYFRA21-1, and p53, are currently used in cancer diagnosis and prognosis, but few of them are ideal for NSCLC because of low sensitivity and specificity (23–25). Here, ENO2 is linked to neoplasm.